MPROS- MOBILE PRO-CTCAE ADMINISTRATION SYSTEM FOR POST-RADIATION TOXICITIES
MPROS- MOBILE PRO-CTCAE ADMINISTRATION SYSTEM FOR POST-RADIATION TOXICITIES
批准号:
10276304
负责人:
JODY UNDERWOOD
金额:
$150.0万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-15 至 2022-09-14
关键词:
AreaCommon Terminology Criteria for Adverse EventsControl GroupsElectronic Health RecordIntuitionMethodsPatient Outcomes AssessmentsPatient Self-ReportPatientsPhaseRadiationRadiation ToxicityRandomized Clinical TrialsReportingRunningSeveritiesStructureSymptomsSystemTestingTimechatbotchemoradiationcommercializationdesignexperienceexperimental grouphealth related quality of lifeimprovedphase 2 studyprogramsresponsesmartphone Applicationsymptom managementusability
中文摘要
mPROS是一款以患者为中心的智能手机应用程序,允许患者舒适地报告由于放疗和放化疗治疗引起的症状。mPROS为临床医生提供了访问患者信息的权限,这些信息可用于及时调整治疗。最终,mPROS将被集成到电子健康记录(EHR)系统中,使临床医生能够无缝访问患者报告的结果。据推测,这种个性化的症状报告将改善患者的健康相关生活质量(HRQOL)。II期研究的主要目的是证明这种益处。第二阶段将完善和改进mPROS中的用户体验和内容,然后进行随机临床试验,通过显示及时和个性化的症状报告可以改善患者的HRQOL来测试其有效性。
英文摘要
mPROS is a patient-centric smartphone app which allows patients to comfortably report symptoms that are due to radiation and chemo-radiation treatment. mPROS provides clinicians with access to patient information that can be used to make timely treatment adjustments. Ultimately, mPROS will be integrated into Electronic Health Record (EHR) systems to make it seamless for clinicians to access patient-reported outcomes. It is hypothesized this individualized symptom reporting will improve patient health-related quality of life (HRQOL). The primary objective of the Phase II study is to demonstrate this benefit. Phase II will refine and improve the user experience and the content in mPROS and then run a randomized clinical trial to test its validity by showing that timely and individualized symptom reporting can result in better patient HRQOL.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金